August 27, 2018



Chief Medical Officer
Randall is a clinical cardiologist and internationally recognized pioneer of predictive analytics monitoring. Working with a clinical neonatologist, he hypothesized that heart rate characteristics monitoring could predict deterioration and lead to early detection of neonatal sepsis. The first and largest study of its kind in neonates showed that predictive analytic monitoring saved lives. As an underpinning of that work, in 2000 he co-developed sample entropy, a popular measure of non-linear dynamics in many physical and biological systems. In 2011, he turned his attention to the adult population and with his research team began to develop algorithms for early detection of catastrophic illness and deterioration in adults across the hospital continuum. He co-founded AMP3D in 2012. He is Professor of Medicine, Physiology and Biomedical Engineering at the University of Virginia, Founding Director of the UVa Center for Advanced Medical Analytics, and Editor-in-Chief of Physiological Measurement. He was the 2014 University of Virginia Innovator of the Year.


President and CEO
After practicing law for several years, Kevin co-founded an enterprise software company in 1999—later backed by Microsoft, Sequoia Capital, and Hg Capital—that sold in a cash transaction in 2006. He then co-founded and co-managed a successful $60 million mid-cap buyout fund. In 2011, Kevin co-founded a mobile hardware company that sold to L Catterton that year. In 2014, he joined AMP3D helping to realize the concepts of predictive analytics monitoring in the real world. Since 2015, Kevin has been the Innovation Fellow at the Biocomplexity Institute of Virginia Tech—among the world’s leading “big data analytics” and “artificial intelligence” academic centers. He is an entrepreneur in residence at both the University of Virginia and Virginia Tech, and a Partner at Buchanan Ingersoll & Rooney PC in Washington, DC where he manages its emerging companies practice. Kevin regularly contributes to international industry forums and panels on technology and entrepreneurship. He graduated from Georgetown University Law Center in 1986, and as valedictorian from St. Vincent College in 1983. He and his wife own a horse farm near Charlottesville.


Chief Science Officer
Matthew is a mechanical engineer and computer scientist. He designs and develops Quality Management System compliant medical device software systems for real-time monitoring of hospitalized patients. He has worked with Moorman and coworkers since 2009. He is an expert in medical device integration, database design, digital signal processing, and mathematical modeling. Matthew’s research focuses on signal processing and mathematical modeling for early detection of catastrophic and potentially avoidable disease in hospitalized patients. He builds algorithms and models into software platforms that provide real-time risk estimation to clinical teams. Early detection made possible by these platforms allows for earlier intervention and better outcomes. Matthew earned his doctoral degree from Virginia Tech in 2008 and his undergraduate degree from Rose-Hulman Institute of Technology in 2004.


Chief Implementation Officer
A former ICU nurse, Liza is an Acute Care Nurse Practitioner with a specialty in cardiac electrophysiology who had a busy clinical practice at the University of Virginia. She was elected Fellow of the international Heart Rhythm Society in 2010 and is a past chair of the society’s Allied Professional Program Committee. During her tenure at UVA, she was integral in hospital system quality initiatives, and developed and implemented best practice protocols and new programs. She taught graduate ACNP students at UVA’s School of Nursing. For AMP3D, she has developed implementation plans and clinical education materials for use of predictive analytics monitoring in bedside clinical care.